Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom; Institute of Cardiovascular Science, University College London, London, United Kingdom.
Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1532-1548. doi: 10.1016/j.jcmg.2019.02.034.
Aortic stenosis (AS) causes left ventricular remodeling (hypertrophy, remodeling, fibrosis) and other cardiac changes (left atrial dilatation, pulmonary artery and right ventricular changes). These changes, and whether they are reversible (reverse remodeling), are major determinants of timing and outcome from transcatheter or surgical aortic valve replacement. Cardiac changes in response to AS afterload can either be adaptive and reversible, or maladaptive and irreversible, when they may convey residual risk after intervention. Structural and hemodynamic assessment of AS therefore needs to evaluate more than the valve, and, in particular, the myocardial remodeling response. Imaging plays a key role in this. This review assesses how multimodality imaging evaluates AS myocardial hypertrophy and its components (cellular hypertrophy, fibrosis, microvascular changes, and additional features such as cardiac amyloid) both before and after intervention, and seeks to highlight how care and outcomes in AS could be improved.
主动脉瓣狭窄(AS)可导致左心室重构(肥厚、重构、纤维化)和其他心脏改变(左心房扩张、肺动脉和右心室改变)。这些改变以及它们是否可以逆转(逆重构)是决定经导管或手术主动脉瓣置换时机和结果的主要因素。AS 后负荷引起的心脏改变可能是适应性和可逆转的,也可能是适应性和不可逆转的,在干预后可能会带来残余风险。因此,AS 的结构和血流动力学评估不仅需要评估瓣膜,还需要特别评估心肌重构反应。影像学在这方面起着关键作用。本综述评估了多模态影像学如何在干预前后评估 AS 心肌肥厚及其成分(细胞肥大、纤维化、微血管改变以及其他特征,如心脏淀粉样变性),并试图强调如何改善 AS 的护理和结局。